Literature DB >> 10574906

Major beta blocker mortality trials in chronic heart failure: a critical review.

J J McMurray1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10574906      PMCID： PMC1766519          DOI： 10.1136/hrt.82.2008.iv14

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  23 in total

1.  Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

Authors:  P Lechat; M Packer; S Chalon; M Cucherat; T Arab; J P Boissel
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

2.  Carvedilol in patients with chronic heart failure.

Authors:  K von Olshausen; T Pop; J Berger
Journal:  N Engl J Med       Date:  1996-10-24       Impact factor: 91.245

3.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  beta Blockade after myocardial infarction: systematic review and meta regression analysis.

Authors:  N Freemantle; J Cleland; P Young; J Mason; J Harrison
Journal:  BMJ       Date:  1999-06-26

Review 5.  Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials.

Authors:  A Avezum; R T Tsuyuki; J Pogue; S Yusuf
Journal:  Can J Cardiol       Date:  1998-08       Impact factor: 5.223

6.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Authors: 
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

7.  A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.

Authors:  J N Cohn; S O Goldstein; B H Greenberg; B H Lorell; R C Bourge; B E Jaski; S O Gottlieb; F McGrew; D L DeMets; B G White
Journal:  N Engl J Med       Date:  1998-12-17       Impact factor: 91.245

8.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Authors:  M Packer; J R Carver; R J Rodeheffer; R J Ivanhoe; R DiBianco; S M Zeldis; G H Hendrix; W J Bommer; U Elkayam; M L Kukin
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

9.  Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee.

Authors: 
Journal:  Am J Cardiol       Date:  1995-06-15       Impact factor: 2.778

10.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245
View more
  5 in total

Review 1.  Modulation of angiotensin II signaling following exercise training in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Hanjun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

2.  Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.

Authors:  A P Maggioni; G Sinagra; C Opasich; E Geraci; M Gorini; E Gronda; D Lucci; G Tognoni; E Balli; L Tavazzi
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

3.  Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden: analysis using data from the Cardiac Insufficiency Bisoprolol Study II trial.

Authors:  M Ekman; N Zethraeus; B Jönsson
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  Patients with worsening chronic heart failure who present to a hospital emergency department require hospital care.

Authors:  Masoud Shafazand; Harshidaben Patel; Inger Ekman; Karl Swedberg; Maria Schaufelberger
Journal:  BMC Res Notes       Date:  2012-03-08

5.  Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure.

Authors:  Yosuke Kayama; Tohru Minamino; Haruhiro Toko; Masaya Sakamoto; Ippei Shimizu; Hidehisa Takahashi; Sho Okada; Kaoru Tateno; Junji Moriya; Masataka Yokoyama; Aika Nojima; Michihiro Yoshimura; Kensuke Egashira; Hiroyuki Aburatani; Issei Komuro
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.